205 related articles for article (PubMed ID: 30880971)
1. Preparation, intestinal segment stability, and mucoadhesion properties of novel thymopentin-loaded chitosan derivatives coated with poly (n-butyl) cyanoacrylate nanoparticles.
Xu Y; Lu S; Liu Q; Hong Y; Xu B; Ping Q; Jin X; Shen Y; Webster TJ; Rao Y
Int J Nanomedicine; 2019; 14():1659-1668. PubMed ID: 30880971
[TBL] [Abstract][Full Text] [Related]
2. Box-Behnken optimization design and enhanced oral bioavailability of thymopentin-loaded poly (butyl cyanoacrylate) nanoparticles.
Jin X; Huang A; Ping Q; Cao F; Su Z
Pharmazie; 2011 May; 66(5):339-47. PubMed ID: 21699067
[TBL] [Abstract][Full Text] [Related]
3. Preparation and evaluation of poly-butylcyanoacrylate nanoparticles for oral delivery of thymopentin.
He W; Jiang X; Zhang ZR
J Pharm Sci; 2008 Jun; 97(6):2250-9. PubMed ID: 17853430
[TBL] [Abstract][Full Text] [Related]
4. Reversion of multidrug resistance by co-encapsulation of doxorubicin and curcumin in chitosan/poly(butyl cyanoacrylate) nanoparticles.
Duan J; Mansour HM; Zhang Y; Deng X; Chen Y; Wang J; Pan Y; Zhao J
Int J Pharm; 2012 Apr; 426(1-2):193-201. PubMed ID: 22274587
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo evaluation of 10-hydroxycamptothecin-loaded poly (n-butyl cyanoacrylate) nanoparticles prepared by miniemulsion polymerization.
Jin X; Asghar S; Zhu X; Chen Z; Tian C; Yin L; Ping Q; Xiao Y
Colloids Surf B Biointerfaces; 2018 Feb; 162():25-34. PubMed ID: 29145001
[TBL] [Abstract][Full Text] [Related]
6. Effects of phospholipid and polyethylene glycol monostearate (100) on the in vitro and in vivo physico-chemical characterization of poly(n-butyl cyanoacrylate) nanoparticles.
Jin X; Asghar S; Zhang M; Chen Z; Zhang J; Ping Q; Xiao Y
Colloids Surf B Biointerfaces; 2019 Jan; 173():320-326. PubMed ID: 30312943
[TBL] [Abstract][Full Text] [Related]
7. Poly(n-butylcyanoacrylate) nanoparticles for oral delivery of quercetin: preparation, characterization, and pharmacokinetics and biodistribution studies in Wistar rats.
Bagad M; Khan ZA
Int J Nanomedicine; 2015; 10():3921-35. PubMed ID: 26089668
[TBL] [Abstract][Full Text] [Related]
8. Thymopentin-loaded pH-sensitive chitosan nanoparticles for oral administration: preparation, characterization, and pharmacodynamics.
Zheng AP; Wang JC; Lu WL; Zhang X; Zhang H; Wang XQ; Zhang Q
J Nanosci Nanotechnol; 2006; 6(9-10):2936-44. PubMed ID: 17048501
[TBL] [Abstract][Full Text] [Related]
9. Enhanced oral bioavailability of 10-hydroxycamptothecin through the use of poly (n-butyl cyanoacrylate) nanospheres.
Jin X; Asghar S; Zhu X; Chen Z; Liu J; Li Y; Li H; Ping Q; Xiao Y
Drug Dev Ind Pharm; 2017 Oct; 43(10):1637-1647. PubMed ID: 28481657
[TBL] [Abstract][Full Text] [Related]
10. The Effect of Polybutylcyanoacrylate Nanoparticles as a Protos Delivery Vehicle on Dental Bone Formation.
Chang LC; Chung CY; Chiu CH; Lin MH; Yang JT
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34062952
[TBL] [Abstract][Full Text] [Related]
11. In vitro-in vivo evaluation of chitosan-PLGA nanoparticles for potentiated gastric retention and anti-ulcer activity of diosmin.
Abd El Hady WE; Mohamed EA; Soliman OAE; El-Sabbagh HM
Int J Nanomedicine; 2019; 14():7191-7213. PubMed ID: 31564873
[TBL] [Abstract][Full Text] [Related]
12. Hyaluronic acid coated poly(butyl cyanoacrylate) nanoparticles as anticancer drug carriers.
He M; Zhao Z; Yin L; Tang C; Yin C
Int J Pharm; 2009 May; 373(1-2):165-73. PubMed ID: 19429302
[TBL] [Abstract][Full Text] [Related]
13. A Comparative Study of Orally Delivered PBCA and ApoE Coupled BSA Nanoparticles for Brain Targeting of Sumatriptan Succinate in Therapeutic Management of Migraine.
Girotra P; Singh SK
Pharm Res; 2016 Jul; 33(7):1682-95. PubMed ID: 27003706
[TBL] [Abstract][Full Text] [Related]
14. Rivastigmine-loaded PLGA and PBCA nanoparticles: preparation, optimization, characterization, in vitro and pharmacodynamic studies.
Joshi SA; Chavhan SS; Sawant KK
Eur J Pharm Biopharm; 2010 Oct; 76(2):189-99. PubMed ID: 20637869
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and in vitro/in vivo anti-cancer evaluation of curcumin-loaded chitosan/poly(butyl cyanoacrylate) nanoparticles.
Duan J; Zhang Y; Han S; Chen Y; Li B; Liao M; Chen W; Deng X; Zhao J; Huang B
Int J Pharm; 2010 Nov; 400(1-2):211-20. PubMed ID: 20813175
[TBL] [Abstract][Full Text] [Related]
16. Design, Preparation, and Evaluation of Osthol Poly-Butyl-Cyanoacrylate Nanoparticles with Improved In Vitro Anticancer Activity in Neuroblastoma Treatment.
Zheng L; Shen L; Li Z; Zhang X; Wu M; Zhang Y; Liu J
Molecules; 2022 Oct; 27(20):. PubMed ID: 36296500
[TBL] [Abstract][Full Text] [Related]
17. Cationic polybutyl cyanoacrylate nanoparticles for DNA delivery.
Duan J; Zhang Y; Chen W; Shen C; Liao M; Pan Y; Wang J; Deng X; Zhao J
J Biomed Biotechnol; 2009; 2009():149254. PubMed ID: 19300519
[TBL] [Abstract][Full Text] [Related]
18. Preparation and evaluation of lectin-conjugated PLGA nanoparticles for oral delivery of thymopentin.
Yin Y; Chen D; Qiao M; Lu Z; Hu H
J Control Release; 2006 Dec; 116(3):337-45. PubMed ID: 17097180
[TBL] [Abstract][Full Text] [Related]
19. N,N,N-trimethylchitosan-poly (n-butylcyanoacrylate) core-shell nanoparticles as a potential oral delivery system for acyclovir.
Tavares GD; Gonçalves JE; Monteiro LM; Löbenberg R; Storpirtis S; Bou-Chacra NA; Consiglieri VO
Colloids Surf B Biointerfaces; 2020 Dec; 196():111336. PubMed ID: 32877830
[TBL] [Abstract][Full Text] [Related]
20. Protective effects of poly (butyl) cyanoacrylate nanoparticles containing vasoactive intestinal peptide against 6-hydroxydopamine-induced neurotoxicity in vitro.
Xu ZR; Wang WF; Liang XF; Liu ZH; Liu Y; Lin L; Zhu X
J Mol Neurosci; 2015 Apr; 55(4):854-64. PubMed ID: 25326789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
